Approved for Treatment of symptomatic BPH in men with an enlarged prostate. Combines dual 5-alpha reductase inhibition (dutasteride) with alpha-1 adrenergic blockade (tamsulosin) for complementary BPH relief. Side effects, costs, interactions, manufacturer, and generic alternatives sourced from FDA labels, openFDA FAERS, and CMS NADAC pricing.
Loading full data from Know Your Drugs Institute…